NCT03336593 - Protectivity and Safety of Quadrivalent Influenza HA Vaccine in Indonesian Population | Biotech Hunter

Enrollment

810

Participants

Timeline

Start Date

November 21, 2017

Primary Completion Date

March 14, 2018

Study Completion Date

November 30, 2018

Conditions

Safety Issues

Interventions

BIOLOGICAL

Quadrivalent Influenza Vaccine

1 or 2 doses of Quadrivalent Influenza Vaccine depends on age

BIOLOGICAL

Trivalent Influenza Vaccine

1 dose of Trivalent Influenza Vaccine

Trial Locations (3)

Garuda Primary Health Center, Bandung

Ibrahim Adjie Primary Health Center, Bandung

Puter Primary Health Center, Bandung